✦ LIBER ✦

Intravitreal recombinant tissue plasminogen activator in the treatment of experimentally induced bacterial endophthalmitis

✍ Scribed by Natalie Baziuk; Ting Fang; Gholam A. Peyman; Charles M. Gremillion

Publisher: Springer Netherlands
Year: 1991
Tongue: English
Weight: 614 KB
Volume: 15
Category: Article
ISSN: 0165-5701
DOI: 10.1007/bf01046426

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The use of free flow electrophoresis in

The use of free flow electrophoresis in the purification of recombinant human tissue plasminogen activator expressed in yeast

✍ Françoise Barth; Dr. Markus G. Gruetter; Reinhard Kessler; Hans-Jörg Manz 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 416 KB

Enhanced poly(ADP-ribose) polymerase-1 a

Enhanced poly(ADP-ribose) polymerase-1 activation contributes to recombinant tissue plasminogen activator-induced aggravation of ischemic brain injury in vivo

✍ Olaf Crome; Thorsten R. Doeppner; Sönke Schwarting; Barbara Müller; Mathias Bähr 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 493 KB

## Abstract Recombinant tissue plasminogen activator (rt‐PA) treatment improves functional outcome after acute ischemic stroke, inducing reperfusion by its thrombolytic activity. Conversely, there is evidence that rt‐PA can mediate neuronal damage after ischemic brain injury in vivo. In addition to

Successful treatment of massive pulmonar

Successful treatment of massive pulmonary embolism with recombinant tissue type plasminogen activator (rt-PA) in a pregnant woman with intact gravidity and preterm labour

✍ Th. Floßdorf; M. Breulmann; H. -B. Hopf 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 482 KB

Microvascular repair following a modifie

Microvascular repair following a modified crush-avulsion injury in a rat model: Effect of recombinant human tissue-type plasminogen activator on the patency rate

✍ Efstathios G. Lykoudis; Petros N. Panayotou; Constantinos N. Stamatopoulos; Kons 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 579 KB

The failure rate of replantations following a crush-avulsion type injury is high. This study has been designed to reproduce an effective standardized crush-avulsion injury model to the femoral artery of the rat and evaluate the antithrombotic efficacy of systemic intravenous administration of recomb

Microsurgical repair after crush-avulsio

Microsurgical repair after crush-avulsion injury of the femoral vein in rats: Prevention of microvascular thrombosis with recombinant human tissue-type plasminogen activator (rt-PA)

✍ Efstathios G. Lykoudis; George B. Contodimos; Dimosthenis A. Tsoutsos; Konstanti 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 284 KB

## Abstract Vein thrombosis is often encountered in microsurgery, especially in the case of crush‐avulsion injuries. The aim of this study was to investigate the effect of systemic administration of recombinant tissue‐type plasminogen activator (rt‐PA) on the patency of the femoral vein of the rat,

Expression of high levels of human tissu

Expression of high levels of human tissue plasminogen activator in yeast under the control of an inducible GAL promoter

✍ E. Martegani; N. Forlani; I. Mauri; D. Porro; W. D. Schleuning; L. Alberghina 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 828 KB

The human tissue plasminogen activator (h-tPA) cDNA was fused either with the leader sequence of the killer toxin of Kluyveromyces lactis or with the Saccharomyces diastaticus glucoamylase leader peptide and cloned in the yeast expression vector under the control of the inducible USAgal/CYC1 promote